Ku80 cooperates with CBP to promote COX-2 expression and tumor growth
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
// Yao Xiao 1,* , Jingshu Wang 2,* , Yu Qin 1 , Yang Xuan 1 , Yunlu Jia 3 , Wenxian Hu 3 , Wendan Yu 1 , Meng Dai 1 , Zhenglin Li 1 , Canhui Yi 1 , Shilei Zhao 1 , Mei Li 1 , Sha Du 1 , Wei Cheng 1 , Xiangsheng Xiao 2 , Yiming Chen 1 , Taihua Wu 1 , Songshu Meng 1 , Yuhui Yuan 1 , Quentin Liu 1,2 , Wenlin Huang 2,4 , Wei Guo 1 , Shusen Wang 2 and Wuguo Deng 1,2,4 1 Institute of Cancer Stem Cell & First Affiliated Hospital, Dalian Medical University, Dalian, China 2 Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China 3 Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China 4 State Key Laboratory of Targeted Drug for Tumors of Guangdong Province, Guangzhou Double Bioproduct Inc., Guangzhou, China * These authors contributed equally to this article Correspondence to: Shusen Wang, email: // Wei Guo, email: // Wuguo Deng, email: // Keywords : Ku80, CBP, COX-2, lung cancer Received : December 30, 2014 Accepted : February 04, 2015 Published : March 08, 2015 Abstract Cyclooxygenase-2 (COX-2) plays an important role in lung cancer development and progression. Using streptavidin-agarose pulldown and proteomics assay, we identified and validated Ku80, a dimer of Ku participating in the repair of broken DNA double strands, as a new binding protein of the COX-2 gene promoter. Overexpression of Ku80 up-regulated COX-2 promoter activation and COX-2 expression in lung cancer cells. Silencing of Ku80 by siRNA down-regulated COX-2 expression and inhibited tumor cell growth in vitro and in a xenograft mouse model. Ku80 knockdown suppressed phosphorylation of ERK, resulting in an inactivation of the MAPK pathway. Moreover, CBP, a transcription co-activator, interacted with and acetylated Ku80 to co-regulate the activation of COX-2 promoter. Overexpression of CBP increased Ku80 acetylation, thereby promoting COX-2 expression and cell growth. Suppression of CBP by a CBP-specific inhibitor or siRNA inhibited COX-2 expression as well as tumor cell growth. Tissue microarray immunohistochemical analysis of lung adenocarcinomas revealed a strong positive correlation between levels of Ku80 and COX-2 and clinicopathologic variables. Overexpression of Ku80 was associated with poor prognosis in patients with lung cancers. We conclude that Ku80 promotes COX-2 expression and tumor growth and is a potential therapeutic target in lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoeijmakers, J. H. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804615 · Cited by 2,239 · cited 1×
“Once DNA damage repair was destroyed, apoptosis might be caused or even more seriously carcinogenesis arised [50, 51].”
BackgroundPalumbo, S., Toscano, C. D., Parente, L., Weigert, R., & Bosetti, F. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07363.x · Cited by 46
Cited by
Zhou, L., Zhang, M., Wang, Y., Dorfman, R. G., Liu, H., Yu, T., Chen, X., Tang, D., Xu, L., Yin, Y., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy182 · Cited by 525
Wang, D., Wang, M., Jiang, N., Zhang, Y., Bian, X., Wang, X., Roberts, T. M., Zhao, J. J., Liu, P., & Cheng, H. (2016) · Oncotarget · doi:10.18632/oncotarget.7549 · Cited by 88
“All IHCs were done as described previously [40].”
MethodIdentification of lysine acetylome in cervical cancer by label-free quantitative proteomics
Zhang, L., Wang, W., Zhang, S., Wang, Y., Guo, W., Liu, Y., Wang, Y., & Zhang, Y. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01266-z · Cited by 15
Self-citation
Metadata
- Authors
- Xiao, Y., Wang, J., Qin, Y., Xuan, Y., Jia, Y., Hu, W., Yu, W., Dai, M., Li, Z., Yi, C., Zhao, S., Li, M., Du, S., Cheng, W., Xiao, X., Chen, Y., Wu, T., Meng, S., Yuan, Y., Liu, Q., Huang, W., Guo, W., Wang, S., & Deng, W.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-03-10
- Volume
- 6
- Issue
- 10
- Pages
- 8046-8061
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1501165518
- Cited by
- 53
- References
- 2
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ku80 cooperates with CBP to promote COX-2 expression and tumor growth. https://app.cochat.ai/papers/10.18632/oncotarget.3508
- The paper
- Xiao, Y., Wang, J., Qin, Y., Xuan, Y., Jia, Y., Hu, W., Yu, W., Dai, M., Li, Z., Yi, C., Zhao, S., Li, M., Du, S., Cheng, W., Xiao, X., Chen, Y., Wu, T., Meng, S., Yuan, Y., . . . Deng, W. (2015). Ku80 cooperates with CBP to promote COX-2 expression and tumor growth. Oncotarget. https://doi.org/10.18632/oncotarget.3508
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.